Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 2
2004 1
2010 1
2011 1
2013 1
2017 1
2018 1
2019 3
2020 2
2021 3
2022 3
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.
Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, Jafri W, Sarin SK; Asia Pacific Association of Study of Liver. Devarbhavi H, et al. Among authors: treeprasertsuk s. Hepatol Int. 2021 Apr;15(2):258-282. doi: 10.1007/s12072-021-10144-3. Epub 2021 Feb 27. Hepatol Int. 2021. PMID: 33641080
An international multidisciplinary consensus statement on MAFLD and the risk of CVD.
Zhou XD, Targher G, Byrne CD, Somers V, Kim SU, Chahal CAA, Wong VW, Cai J, Shapiro MD, Eslam M, Steg PG, Sung KC, Misra A, Li JJ, Brotons C, Huang Y, Papatheodoridis GV, Sun A, Yilmaz Y, Chan WK, Huang H, Méndez-Sánchez N, Alqahtani SA, Cortez-Pinto H, Lip GYH, de Knegt RJ, Ocama P, Romero-Gomez M, Fudim M, Sebastiani G, Son JW, Ryan JD, Ikonomidis I, Treeprasertsuk S, Pastori D, Lupsor-Platon M, Tilg H, Ghazinyan H, Boursier J, Hamaguchi M, Nguyen MH, Fan JG, Goh GB, Al Mahtab M, Hamid S, Perera N, George J, Zheng MH. Zhou XD, et al. Among authors: treeprasertsuk s. Hepatol Int. 2023 Aug;17(4):773-791. doi: 10.1007/s12072-023-10543-8. Epub 2023 May 19. Hepatol Int. 2023. PMID: 37204656 Free PMC article.
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases.
Fang C, An J, Bruno A, Cai X, Fan J, Fujimoto J, Golfieri R, Hao X, Jiang H, Jiao LR, Kulkarni AV, Lang H, Lesmana CRA, Li Q, Liu L, Liu Y, Lau W, Lu Q, Man K, Maruyama H, Mosconi C, Örmeci N, Pavlides M, Rezende G, Sohn JH, Treeprasertsuk S, Vilgrain V, Wen H, Wen S, Quan X, Ximenes R, Yang Y, Zhang B, Zhang W, Zhang P, Zhang S, Qi X. Fang C, et al. Among authors: treeprasertsuk s. Hepatol Int. 2020 Jul;14(4):437-453. doi: 10.1007/s12072-020-10052-y. Epub 2020 Jul 7. Hepatol Int. 2020. PMID: 32638296 Free PMC article.
Nonalcoholic fatty liver disease and the coronary artery disease.
Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Treeprasertsuk S, et al. Dig Dis Sci. 2011 Jan;56(1):35-45. doi: 10.1007/s10620-010-1241-2. Epub 2010 May 13. Dig Dis Sci. 2011. PMID: 20464495 Review.
The combination of lifestyle modification with pharmacological treatment tailored to each individual's risk factors needs to be considered. There is a need for more research on primary prevention for CAD in NAFLD patients and interventional studies for determining the natu …
The combination of lifestyle modification with pharmacological treatment tailored to each individual's risk factors needs to be consi …
Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.
Teerasarntipan T, Sritunyarat Y, Prathyajuta P, Pitakkitnukun P, Phathong C, Ariyaskul D, Kulkraisri K, Tangkijvanich P, Treeprasertsuk S, Rerknimitr R, Chaiteerakij R. Teerasarntipan T, et al. Among authors: treeprasertsuk s. Medicine (Baltimore). 2022 Sep 9;101(36):e30538. doi: 10.1097/MD.0000000000030538. Medicine (Baltimore). 2022. PMID: 36086710 Free article.
We aimed to identify HCC surveillance barriers from both physician's and patient's perspectives and assess the effectiveness of physician education using social networks. ...The main surveillance barriers among physicians were the lack of knowledge and resource limi …
We aimed to identify HCC surveillance barriers from both physician's and patient's perspectives and assess the effectiveness o …
COVID-19 active case findings based on self-collected saliva samples with CRISPR-Cas12a detection.
Chantaravisoot N, Kaewsapsak P, Mayuramart O, Nimsamer P, Mankhong S, Chomta N, Bootsri R, Alee I, Wongkongkathep P, Treeprasertsuk S, Payungporn S. Chantaravisoot N, et al. Among authors: treeprasertsuk s. Exp Biol Med (Maywood). 2022 Jul;247(14):1228-1234. doi: 10.1177/15353702221090181. Epub 2022 Apr 27. Exp Biol Med (Maywood). 2022. PMID: 35473361 Free PMC article.
Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients.
Thanapirom K, Wongwandee M, Suksawatamnuay S, Thaimai P, Siripon N, Makhasen W, Treeprasertsuk S, Komolmit P. Thanapirom K, et al. Among authors: treeprasertsuk s. J Clin Med. 2023 Jan 8;12(2):519. doi: 10.3390/jcm12020519. J Clin Med. 2023. PMID: 36675448 Free PMC article.
Moreover, MHE was found to be present in 26.6% of cirrhotic patients. S-ANT1 had a moderate positive correlation with PHES (r = 0.44, p < 0.001). ...The optimal cutoff for detecting MHE in Thai cirrhotic patients was PHES 5 points and S-ANT1 < 22 named....
Moreover, MHE was found to be present in 26.6% of cirrhotic patients. S-ANT1 had a moderate positive correlation with PHES (r = 0.44, …
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure.
Thanapirom K, Teerasarntipan T, Treeprasertsuk S, Choudhury A, Sahu MK, Maiwall R, Pamecha V, Moreau R, Al Mahtab M, Chawla YK, Devarbhavi H, Yu C, Ning Q, Amarapurkar D, Eapen CE, Hamid SS, Butt AS, Kim DJ, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Yuen MF, Chan A, Lau G, Jia J, Rahman S, Sharma BC, Yokosuka O, Sarin SK; APASL ACLF Working Party. Thanapirom K, et al. Among authors: treeprasertsuk s. Hepatol Int. 2022 Feb;16(1):171-182. doi: 10.1007/s12072-021-10266-8. Epub 2021 Nov 25. Hepatol Int. 2022. PMID: 34822057 Free PMC article.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Younossi ZM, AlQahtani SA, Alswat K, Yilmaz Y, Keklikkiran C, Funuyet-Salas J, Romero-Gómez M, Fan JG, Zheng MH, El-Kassas M, Castera L, Liu CJ, Wai-Sun Wong V, Zelber-Sagi S, Allen AM, Lam B, Treeprasertsuk S, Hameed S, Takahashi H, Kawaguchi T, Schattenberg JM, Duseja A, Newsome PN, Francque S, Spearman CW, Castellanos Fernández MI, Burra P, Roberts SK, Chan WK, Arrese M, Silva M, Rinella M, Singal AK, Gordon S, Fuchs M, Alkhouri N, Cusi K, Loomba R, Ranagan J, Eskridge W, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Yu ML, Gerber L, Fornaresio L, Nader F, Henry L, Racila A, Golabi P, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council. Younossi ZM, et al. Among authors: treeprasertsuk s. J Hepatol. 2023 Nov 18:S0168-8278(23)05279-0. doi: 10.1016/j.jhep.2023.11.004. Online ahead of print. J Hepatol. 2023. PMID: 37984709
The most popular response was being neither comfortable nor uncomfortable with either term (56%-71%), with some greater discomfort with "FLD" among the U.S. and South Asian patients (47-52% uncomfortable). Although 26% of patients reported stigma related to overweight/obes …
The most popular response was being neither comfortable nor uncomfortable with either term (56%-71%), with some greater discomfort with "FLD …
21 results